Akorn Inc (AKRX)

19.88
0.11 0.55
NASDAQ : Health Care
Prev Close 19.99
Open 19.92
Day Low/High 19.59 / 20.11
52 Wk Low/High 17.57 / 47.35
Volume 1.77M
Avg Volume 1.42M
Exchange NASDAQ
Shares Outstanding 125.24M
Market Cap 2.66B
EPS 1.30
P/E Ratio 35.97
Div & Yield N.A. (N.A)

Latest News

Akorn Stock Sees Short Interest Move 15.3% Lower

Akorn Stock Sees Short Interest Move 15.3% Lower

The most recent short interest data has been released for the 11/15/2016 settlement date, which shows a 1,867,919 share decrease in total short interest for Akorn Inc , to 10,324,737, a decrease of 15.32% since 10/31/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CCJ, CMC, DF, DLNG, GATX, PCH, PFNX, PRAH, RDY, TMHC, VLO Downgrades: AKRX, BETR, EDGW, HLTH, KNDI, PRMW, SONC, VWR Initiations: RGNX Read on to get TheStreet Quant Ratings' detailed report:

Analysts' Actions -- Biogen, GoPro, L Brands, Time Warner and More

Analysts' Actions -- Biogen, GoPro, L Brands, Time Warner and More

Here are Monday's top research calls, including upgrades for Biogen and Time Warner, and downgrades for GoPro and L Brands.

Analysts' Actions -- Express Scripts, Lions Gate, Qorvo, Whole Foods and More

Analysts' Actions -- Express Scripts, Lions Gate, Qorvo, Whole Foods and More

Here are Friday's top research calls, including upgrades for Express Scripts and Lions Gate, and downgrades for Qorvo and Whole Foods.

Health Sector Down As Report of Industry Price Collusion Surfaces

Health Sector Down As Report of Industry Price Collusion Surfaces

The healthcare sector was dragged down by reports of price collusion and worse-than-expected third-quarter profits.

Akorn (AKRX) Stock Gains, Rating Raised at Piper Jaffray

Akorn (AKRX) Stock Gains, Rating Raised at Piper Jaffray

Akorn's (AKRX) stock rating was boosted to 'overweight' at Piper Jaffray on Thursday morning.

5 Stocks to Trade for Big Breakout Gains

5 Stocks to Trade for Big Breakout Gains

These stocks are within range of triggering big breakout trades.

'Mad Money' Lightning Round: Take Nucor Over U.S. Steel

'Mad Money' Lightning Round: Take Nucor Over U.S. Steel

Cramer is only blessing Box and Akorn for speculation.

Jim Cramer's 'Mad Money' Recap: We've Come a Long Way From Last Year

Jim Cramer's 'Mad Money' Recap: We've Come a Long Way From Last Year

A year ago the market was in a massive tailspin. It survived and has been going up ever since, Cramer says.

Analysts' Actions -- FireEye, Kraft, Teva, U.S. Steel and More

Analysts' Actions -- FireEye, Kraft, Teva, U.S. Steel and More

Here are Friday's top research calls, including downgrades for FireEye and Teva Pharmaceuticals, and upgrades for Kraft Heinz and U.S. Steel.

Akorn (AKRX) Stock Drops Despite Q2 Beat

Akorn (AKRX) Stock Drops Despite Q2 Beat

Akorn (AKRX) stock is slipping in late-afternoon trading despite the company reporting better-than-expected results for the second quarter before today's opening bell.

Pricing Stress may Weigh on Generic Drugmakers Ahead of Q2 Earnings

Pricing Stress may Weigh on Generic Drugmakers Ahead of Q2 Earnings

Endo Pharmaceuticals is most under pressure, analysts say.

Analysts Differ On Impact Of Valeant's Rejected Takeover Bid

Analysts Differ On Impact Of Valeant's Rejected Takeover Bid

Shares of Valeant Pharmaceuticals jumped following last night's report by The Wall Street Journal saying that the company rejected a joint takeover approach from Takeda Pharmaceuticals and TGP Capital.

AKRX Crosses Above Key Moving Average Level

AKRX Crosses Above Key Moving Average Level

In trading on Friday, shares of Akorn Inc crossed above their 200 day moving average of $30.60, changing hands as high as $30.84 per share. Akorn Inc shares are currently trading up about 3% on the day.

5 Stocks Set to Soar on Bullish Earnings

5 Stocks Set to Soar on Bullish Earnings

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AKRX, ALJJ, NYRT, PSEC, SAND, STO, WWE Downgrades: ABT, AMCN, CRAY, GBDC, MTSC, WEYS Initiations: CLLS, XHR Read on to get TheStreet Quant Ratings' detailed report: